Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ISRCTN51391184) titled 'DNA methylation analysis on self-samples for cervical cancer detection' on April 20.
Study Type: Observational
Study Design:
Observational retrospective multi-center equivalence study
Primary Sponsor: Self-screen B.V.
Condition:
Cervical (pre)cancer
Cancer
Intervention:
At least 70 high-risk HPV+ women with CIN3+ and 70 high-risk HPV+ women without evidence of disease (or at maximum CIN1
Recruitment Status: Recruiting
Phase: Not Applicable
Date of First Enrollment: 01/03/2026
Target Sample Size: 140
Countries of Recruitment:
Uzbekistan
To know more, visit https://www.isrctn.com/ISRCTN51391184
Pu...